IART - Integra LifeSciences Holdings Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.44B
Enterprise Value 5.60B
Trailing P/E 25.09
Forward P/E 15.48
PEG Ratio (5 yr expected) 1.56
Price/Sales (ttm)2.91
Price/Book (mrq)2.46
Enterprise Value/Revenue 3.58
Enterprise Value/EBITDA 20.93

Trading Information

Stock Price History

Beta (5Y Monthly) 1.15
52-Week Change 3-35.23%
S&P500 52-Week Change 33.90%
52 Week High 361.66
52 Week Low 337.36
50-Day Moving Average 352.00
200-Day Moving Average 352.17

Share Statistics

Avg Vol (3 month) 3652.8k
Avg Vol (10 day) 31.56M
Shares Outstanding 581.9M
Implied Shares Outstanding 6N/A
Float 870.82M
% Held by Insiders 113.09%
% Held by Institutions 194.60%
Shares Short (May 14, 2023) 42.93M
Short Ratio (May 14, 2023) 45.2
Short % of Float (May 14, 2023) 44.11%
Short % of Shares Outstanding (May 14, 2023) 43.58%
Shares Short (prior month Apr 13, 2023) 43.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Jan 03, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 11.00%
Operating Margin (ttm)17.32%

Management Effectiveness

Return on Assets (ttm)4.56%
Return on Equity (ttm)10.45%

Income Statement

Revenue (ttm)1.56B
Revenue Per Share (ttm)18.92
Quarterly Revenue Growth (yoy)1.10%
Gross Profit (ttm)982.03M
EBITDA 390.26M
Net Income Avi to Common (ttm)171.88M
Diluted EPS (ttm)2.11
Quarterly Earnings Growth (yoy)-26.40%

Balance Sheet

Total Cash (mrq)323.03M
Total Cash Per Share (mrq)3.94
Total Debt (mrq)1.61B
Total Debt/Equity (mrq)96.32
Current Ratio (mrq)3.65
Book Value Per Share (mrq)20.45

Cash Flow Statement

Operating Cash Flow (ttm)246.28M
Levered Free Cash Flow (ttm)212.63M